KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Long-Term Deferred Tax (2016 - 2025)

Bausch Health Companies' Long-Term Deferred Tax history spans 17 years, with the latest figure at $2.1 billion for Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax fell 6.31% year-over-year to $2.1 billion; the TTM value through Sep 2025 reached $2.1 billion, down 6.31%, while the annual FY2024 figure was $2.0 billion, 6.33% down from the prior year.
  • Long-Term Deferred Tax for Q3 2025 was $2.1 billion at Bausch Health Companies, up from $2.0 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $2.4 billion in Q3 2022 and bottomed at $2.0 billion in Q4 2024.
  • The 5-year median for Long-Term Deferred Tax is $2.2 billion (2024), against an average of $2.2 billion.
  • The largest annual shift saw Long-Term Deferred Tax increased 23.56% in 2021 before it dropped 8.0% in 2025.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $2.3 billion in 2021, then dropped by 3.82% to $2.2 billion in 2022, then decreased by 3.0% to $2.1 billion in 2023, then dropped by 6.33% to $2.0 billion in 2024, then increased by 4.17% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Long-Term Deferred Tax are $2.1 billion (Q3 2025), $2.0 billion (Q2 2025), and $2.0 billion (Q1 2025).